Last $1.72 USD
Change Today -0.03 / -1.71%
Volume 89.8K
PIP On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eric I. Richman

Chief Executive Officer, President and Director, PharmAthene, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 4 different industries.

See Board Relationships
53$980,215
As of Fiscal Year 2013

Background*

Mr. Eric I. Richman has been the Chief Executive Officer of PharmAthene Inc. since October 21, 2010 and has been its President since March 25, 2010. Mr. Richman served as an Interim Chief Executive Officer of PharmAthene, Inc. from May 2, 2010 to October 21, 2010. He served as the Chief Operating Officer of PharmAthene, Inc. since March 25, 2010. He served as Senior Vice President of Business Development and Strategic Planning of PharmAthene, Inc. since August 3, 2007 ...

Read Full Background

Corporate Headquarters*

One Park Place
Annapolis, Maryland 21401

United States

Phone: 410-269-2600
Fax: 410-269-2601

Board Members Memberships*

Former Director
2004-N/A
Independent Director, Chairman of Compensation Committee and Chairman of Commercialization Oversight Committee
2007-Present
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Governance & Nominations Committee
2010-Present
Chief Executive Officer, President and Director

Education*

BS 1984
The City College of New York
MBA
Thunderbird School of Global Management

Other Affiliations*

Annual Compensation*

Salary$456,187
Total Annual Compensation$456,187

Stock Options*

Exercisable Options1,074,279
Exercisable Options Value$208,160
Unexercisable Options331,250
Unexercisable Options Value$136,625
Total Value of Options$344,784
Total Number of Options1,405,529

Total Compensation*

Total Annual Cash Compensation$524,615
Total Short Term Compensation$456,187
Total Calculated Compensation$980,215
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PIP:US $1.72 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
David Aviezer Ph.D., M.B.A.Chief Executive Officer, President, Executive Director and Chief Executive Officer of Protalix Ltd
Protalix BioTherapeutics, Inc.
$577.7K
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMATHENE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.